Literature DB >> 18846477

Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.

Hans-Jacob Bangstad1, Ingebjørg Seljeflot, Tore J Berg, Kristian F Hanssen.   

Abstract

OBJECTIVE: Diabetic nephropathy has been considered to be primarily of glomerular origin, but there is now compelling evidence that disruption of the tubulointerstitial architecture determines the outcome of diabetic nephropathy in interplay with the glomerular damage. We investigated whether reactive oxidative species, pro-inflammatory cytokines and endothelial dysfunction were implicated in the progression of tubulointerstitial damage in young subjects with type 1 diabetes.
MATERIAL AND METHODS: In a prospective study, we investigated 18 young subjects (mean age 21 years) with type 1 diabetes and microalbuminuria. Quantitative morphometry concerning glomerular and tubulointerstitial changes was performed at baseline (i.e. mean duration of diabetes 10 years) and 2.5 and 8 years later. Markers of endothelial activation and inflammation, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumour necrosis factor-alpha, interleukin-6, interleukin-8 and highly sensitive C-reactive protein were measured at baseline and after 8 years. Tissue plasminogen activator antigen and plasminogen activator inhibitor (PAI-1 activity) and asymmetric dimethylargine (ADMA) were measured at baseline and after 2.5 years.
RESULTS: PAI-1 activity at baseline was a significant independent variable of the 8-year increment in interstitial volume fraction (Vv(Int/cortex)). ADMA/L-arginine ratio at baseline was associated with the increment in Vv(Int/cortex) during 2.5 years (p<0.01), still significant after adjustment for covariates (p = 0.02). No associations between Vv(Int/cortex) and glomerular parameters, HaemoglobinA1c and urinary albumin excretion were observed.
CONCLUSIONS: Biomarkers involved in interstitial volume expansion seem to be different from those of mesangial expansion in early diabetic nephropathy. PAI-1 activity may have a predictive role in the development of the tubulointerstitial expansion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18846477     DOI: 10.1080/00365510802444080

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  12 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

Review 2.  Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

Authors:  Ana Marice Ladeia; Raphael Ribeiro Sampaio; Maiara Costa Hita; Luis F Adan
Journal:  World J Diabetes       Date:  2014-10-15

3.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Authors:  Vishal S Vaidya; Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; Fitz B Collings; James H Warram; Andrzej S Krolewski; Joseph V Bonventre
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

4.  Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Authors:  Riyaz Mohamed; Calpurnia Jayakumar; Feng Chen; David Fulton; David Stepp; Ron T Gansevoort; Ganesan Ramesh
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

5.  Transforming growth factor-β1/Smad3-independent epithelial-mesenchymal transition in type I collagen glomerulopathy.

Authors:  Amanda C Brodeur; Anna M Roberts-Pilgrim; Kimberlee L Thompson; Craig L Franklin; Charlotte L Phillips
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-31

Review 6.  Tubulointerstitial Biomarkers for Diabetic Nephropathy.

Authors:  Bancha Satirapoj
Journal:  J Diabetes Res       Date:  2018-02-08       Impact factor: 4.011

7.  Hypertension and the development of new onset chronic kidney disease over a 10 year period: a retrospective cohort study in a primary care setting in Malaysia.

Authors:  Yook Chin Chia; Siew Mooi Ching
Journal:  BMC Nephrol       Date:  2012-12-24       Impact factor: 2.388

8.  Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy.

Authors:  Sang Soo Kim; Sang Heon Song; In Joo Kim; Yun Kyung Jeon; Bo Hyun Kim; Ihm Soo Kwak; Eun Kyung Lee; Yong Ki Kim
Journal:  Diabetes Care       Date:  2012-10-23       Impact factor: 19.112

Review 9.  Guidance cue netrin-1 and the regulation of inflammation in acute and chronic kidney disease.

Authors:  Punithavathi Ranganathan; Riyaz Mohamed; Calpurnia Jayakumar; Ganesan Ramesh
Journal:  Mediators Inflamm       Date:  2014-06-03       Impact factor: 4.711

Review 10.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.